Therapeutics
| Therapeutic
Proteins to 2016 |
While the ability of recombinant protein drugs to treat
previously refractory conditions continues to generate
excitement and investment, the complex structure of these
therapeutic substances require special formulation and
delivery strategies, creating special challenges for drug
developers and their formulation tech ........ more
The administration of therapeutic antibodies via injection
is becoming an increasingly important healthcare treatment
method for a growing number diseases and indications having
broad implications for patient health and well-being. The
inherent instability of protein drugs has led to a number of
challenges as the developers ....
more
| Patient
Controlled Analgesia |
An increasing understanding of the physiology of pain
coupled with patient-friendly dosage forms and delivery
techniques is providing caregivers and prescribers with
improved tools for helping patient manage their own pain.
New and emerging pain delivery products that allow patients
to play an active role in the timing and dosing of their
pain medication ....
more
| Fentanyl:
Products, Markets, Strategies and Opportunities |
.....is available in sustained release dosage forms from a
number of drug suppliers. Fentanyl has demonstrated
effectiveness against breakthrough pain and has become a
commonly prescribed pain medication for most forms of
cancer. Controlled release formulations that include
transdermal patches and transmucosal tablets ..... more
| Controlled
Release Cardiovascular Therapeutics |
The prevalence and incidence of cardiovascular conditions in
developed economies continue to increase, creating
challenges and opportunities for cardiovascular drug
developers. While the vast majority of drugs for treating
cardiovascular conditions are oral immediate release
products, issues related to ..... more
| Autoimmune
Disease Therapeutics to 2016 |
As a group, autoimmune diseases represent one of the most
intractable families of conditions facing medical science.
The complexities and genetic underpinnings of the human
immune response result in a set of disease targets that are
at once physiologically ubiquitous and highly
individualized. Until recently, autoimmune disease patients
were ..... more
| Extended
Release CNS Therapeutics |
The availability of approved drugs for neurological
disorders with extended release profiles creates the
potential to improve patient compliance by extending the
time between dosing intervals. Drugs that have been
formulated as extended release versions include a number of
well-known APIs that have traditionally been marketed as
immediate release ..... more
| Drug
Coatings & Coated Device Drug Delivery |
Advances in coating technology have given rise to a new
generation of coating formulations that can reliably deliver
therapeutic substances from the surface of an implanted
medical device. In currently approved products, these
devices provide a primary function, with the drug
contributing therapeutic benefit that improves ....
more
Much of the interest in needle-free injectors is focused on
chronic diseases and refractory conditions – aliments that
require frequent drug administration for a protracted period
of ....
more
|